drugset / Trial / NCT04677062

Safety, Galenic Acceptability and Efficacy of GV-328 Lozenges in Children With Oral Aphthosis

NCT04677062 ↗

NaSingle-groupOpen-labelTreatment

Summary

The aim of the study was to assess the safety, acceptability, and efficacy of product GV-328 for the treatment of childhood oral aphthous lesion.

Timeline

Start
2017-11-01
Primary completion
2019-06-30
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject GV-328 Unknown 4 unknown Oral
Subject GV-328 Unknown 5 unknown Oral
Subject GV-328 Unknown 6 unknown Oral

Indications